← All Bausch & Lomb CORP filings

Bausch & Lomb CORP 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

NYSE
BLCO
Bausch & Lomb CORP
10-K: Bausch + Lomb Reports Fiscal Year 2024 Results; Separation from Bausch Health Still Under Consideration
Bausch + Lomb's 2024 annual report reveals a 16% revenue increase, driven by volume growth and strategic acquisitions, while the company continues to evaluate options for separating from Bausch Health.
NYSE
BLCO
Bausch & Lomb CORP
10-K: Bausch + Lomb Navigates Market Volatility, Focuses on Growth in 2023
Bausch + Lomb's 2023 10-K filing reveals a year of strategic acquisitions, revenue growth, and ongoing efforts to manage economic headwinds and prepare for future separation from Bausch Health Companies Inc.